Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Jamile M. Shammo is Associate Professor of Medicine and Pathology, Section of Hematology and Stem Cell Transplantation, Division of Hematology/Oncology, at Rush University Medical Center in Chicago, Illinois, where she spearheads the MDS/MPN/Bone Marrow Failure Program. As principal investigator of clinical trials in her area of expertise, and as chair of the protocol review and monitoring committee at Rush Cancer Institute; Dr. Shammo is heavily involved in education, research and administrative activities in the Division of Hematology/Oncology. She is recognized nationally for her expertise in bone marrow failure syndromes/PNH, and was chosen to serve in the role of a national coordinator for the U.S. PNH registry.
Dr. Shammo earned her medical degree from Aleppo Medical School in Syria, after which she sought further education in the U.S., and completed residencies in Anatomic, and Clinical Pathology, as well as Internal Medicine at McGaw Medical Center of Northwestern University, in Evanston, Illinois. She then completed a 3-year fellowship in the Division of Hematology/Oncology at the University of Chicago.